Navigation Links
U.N. Secretary-General Appoints Ray Chambers as His First Special Envoy for the Financing of the Health-Related Millennium Development Goals
Date:3/1/2013

New York, NY (PRWEB) March 01, 2013

GBCHealth is pleased to announce today that the UN Secretary-General has appointed Ray Chambers as his first Special Envoy for Financing of the Health Related Millennium Development Goals (MDGs) and has renewed his mandate on malaria.

In this expanded role, Mr. Chambers, who is Co-chair of GBCHealth, will promote increased investment by the public and private sectors to reduce child and maternal mortality, HIV/AIDS, malaria, tuberculosis and other diseases by 31 December 2015, the internationally agreed deadline for achieving the MDGs.

“Mr. Chambers has been very successful in mobilizing resources and public-private partnership in the fight against malaria,” said UN Secretary-General Ban Ki-moon. “Now, with the urgent need to secure funding for the health-related MDGs, I have asked the Special Envoy to develop a business plan to ensure that we have the resources to achieve our goals.”

Since his appointment as Special Envoy for Malaria in February 2008, visibility, awareness, and funding for malaria have each increased exponentially, with over $4 billion raised, over 400 million mosquito nets distributed and millions of treatment courses administered.

Yet difficulties in bringing malaria deaths down to near-zero by the end of 2015 highlight a broader challenge: ensuring the availability of financial resources. The Secretary-General’s appointment of Mr. Chambers to this expanded role seeks to catalyze new efforts in this regard.

“This new post is essential for financing of the urgent global health targets reflected in the MDGs, and Ray Chambers is the ideal person to lead it,” said Gary Cohen, Acting CEO of GBCHealth and CEO of the MDG Health Alliance.

Mr. Chambers, a philanthropist, is the founding Chairman of the Points of Light Foundation; co-founder, with Former Secretary of State Colin Powell, of America’s Promise -- The Alliance for Youth; and co-founder of Malaria No More. He has served as one of the Secretary-General’s MDG Advocates since 2010. In 2012, Mr. Chambers founded the MDG Health Alliance and most recently, in January, Mr. Chambers joined the Board of Directors of GBCHealth as Co-Chair. He previously served as Chairman of The Millennium Promise Alliance and as Chairman of Wesray Capital Corporation, which he co-founded with Mr. William E. Simon.

About GBCHealth
GBCHealth represents over 200 private sector companies leading the business fight for improved global health. Through work that includes developing comprehensive workplace policies; supporting community programs; leveraging core competencies; facilitating leadership and advocacy by business leaders; and brokering public-private partnerships, GBCHealth helps members achieve their global health goals. GBCHealth also manages the private sector delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, serving as an entry-point for corporate collaboration and engagement with the Fund and its recipients worldwide. GBCHealth has offices in New York, Johannesburg, Beijing, and Nairobi. For more information on GBCHealth, please visit http://www.gbchealth.org

Read the full story at http://www.prweb.com/releases/2013/3/prweb10457651.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Private Real Estate Investment Firm, Cohen Asset Management, Inc., Appoints Senior Vice President of Asset Management for East Coast
2. Dynarex Corporation Appoints a New National Sales Manager to Lead their Sales Organization
3. PaloDEx Appoints Brian Broncatti to the Position of Vice President North America
4. Life Support Technologies Group Appoints Edward Golembe, MD as Co-Clinical Director
5. Life Support Technologies Group Appoints Scott Gorenstein, MD as Co-Clinical Director
6. EPC Group Appoints Industry Veteran to Lead Development Practice Expansion
7. Eagle Village Appoints Mike Mischley and Dani Montini to Board of Directors
8. Experimental Chemo Combo for Colon Cancer Disappoints
9. Geoff Neupert, StrongFirst Master Kettlebell Instructor, Releases New Video Showing the Best Upper Body Exercises to Use in Traditional Kettlebell Workouts
10. NYC Chiropractor Will Soon be the First Chiropractor in New York to Offer ISCS 2.0 Non Surgical Spinal Decompression
11. Educational First Steps Hosts Early Childhood Education Conference and Symposium for Over 500 Early Childhood Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: